Response to "Co-infections in COVID-19 critically ill and antibiotic management: a prospective cohort analysis".
作者信息
Nieuwenhuis Marieke B, Van Biesen Stefaan, Juffermans Nicole P
机构信息
Department of Intensive Care Medicine, OLVG Hospital, Amsterdam, The Netherlands.
Laboratory of Experimental Intensive Care and Anesthesiology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
出版信息
Crit Care. 2020 Sep 29;24(1):591. doi: 10.1186/s13054-020-03308-4.
Abstract
摘要
相似文献
1
Response to "Co-infections in COVID-19 critically ill and antibiotic management: a prospective cohort analysis".对《新冠肺炎危重症患者的合并感染与抗生素管理：一项前瞻性队列分析》的回应
Crit Care. 2020 Sep 29;24(1):591. doi: 10.1186/s13054-020-03308-4.
2
Early administered antibiotics do not impact mortality in critically ill patients with COVID-19.早期使用抗生素对新冠肺炎危重症患者的死亡率没有影响。
J Infect. 2020 Aug;81(2):e148-e149. doi: 10.1016/j.jinf.2020.06.004. Epub 2020 Jun 5.
3
Is previous influenza-like illness a potential Trojan horse for COVID-19?既往流感样疾病会成为新冠病毒的潜在“特洛伊木马”吗？
Crit Care. 2020 Aug 14;24(1):503. doi: 10.1186/s13054-020-03226-5.
4
Study of critically ill patients with COVID-19 in New York City.纽约市新冠肺炎危重症患者的研究。
Lancet. 2020 Oct 10;396(10257):1064. doi: 10.1016/S0140-6736(20)32072-9.
5
Study of critically ill patients with COVID-19 in New York City - Authors' reply.纽约市新冠肺炎危重症患者的研究——作者回复
Lancet. 2020 Oct 10;396(10257):1064. doi: 10.1016/S0140-6736(20)32067-5.
6
Response to 'Impact of immunosuppression on mortality in critically ill COVID-19 patients'.对《免疫抑制对危重症COVID-19患者死亡率的影响》的回应
Br J Haematol. 2020 Nov;191(3):505-506. doi: 10.1111/bjh.17110. Epub 2020 Oct 26.
7
Critically ill patients with COVID-19 in New York City.纽约市的新冠肺炎危重症患者。
Lancet. 2020 Jun 6;395(10239):1740-1741. doi: 10.1016/S0140-6736(20)31190-9. Epub 2020 May 19.
8
Preliminary therapeutic drug monitoring data of β-lactams in critically ill patients with SARS-CoV-2 infection.新型冠状病毒肺炎重症患者β-内酰胺类药物的初步治疗药物监测数据
Anaesth Crit Care Pain Med. 2020 Jun;39(3):387-388. doi: 10.1016/j.accpm.2020.04.005. Epub 2020 Apr 18.
9
Aerosol Barrier Hood for Use in the Management of Critically Ill Adults With COVID-19.用于管理患有新冠肺炎的危重症成人患者的气溶胶屏障头罩
Ann Emerg Med. 2020 Sep;76(3):370-371. doi: 10.1016/j.annemergmed.2020.04.030. Epub 2020 Apr 22.
10
Mobile X-rays are highly valuable for critically ill COVID patients.移动X光机对危重症新冠患者非常有价值。
Eur Radiol. 2020 Sep;30(9):5217-5219. doi: 10.1007/s00330-020-06918-2. Epub 2020 May 13.
引用本文的文献
1
Coinfections and Superinfections Associated with COVID-19 in Colombia: A Narrative Review.哥伦比亚 COVID-19 相关的合并感染和再感染：一项叙事性综述。
Medicina (Kaunas). 2023 Jul 20;59(7):1336. doi: 10.3390/medicina59071336.
2
Random effects meta-analysis of COVID-19/S. aureus partnership in co-infection.新冠病毒/金黄色葡萄球菌合并感染相关性的随机效应荟萃分析。
GMS Hyg Infect Control. 2020 Nov 27;15:Doc29. doi: 10.3205/dgkh000364. eCollection 2020.
本文引用的文献
1
Co-infections in COVID-19 critically ill and antibiotic management: a prospective cohort analysis.新冠重症患者的合并感染与抗生素管理：一项前瞻性队列分析
Crit Care. 2020 Jul 9;24(1):410. doi: 10.1186/s13054-020-03135-7.
2
Co-infections in people with COVID-19: a systematic review and meta-analysis.COVID-19 患者合并感染：系统评价和荟萃分析。
J Infect. 2020 Aug;81(2):266-275. doi: 10.1016/j.jinf.2020.05.046. Epub 2020 May 27.
3
Global and local epidemiology of community-acquired pneumonia: the experience of the CAPNETZ Network.社区获得性肺炎的全球及局部流行病学：CAPNETZ网络的经验
Semin Respir Crit Care Med. 2009 Apr;30(2):127-35. doi: 10.1055/s-0029-1202941. Epub 2009 Mar 18.
Zotero 插件